Actively Recruiting
The Ambient Light Multiple Myeloma Study
Led by Icahn School of Medicine at Mount Sinai · Updated on 2025-06-03
200
Participants Needed
2
Research Sites
228 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The aim of this multi-site randomized control trial will be is to assess the impact Systematic lighting on circadian rhythm entrainment, Inflammation, Neutropenic Fever and Symptom Burden among Multiple Myeloma Patients undergoing Autologous Stem Cell Transplantation. To achieve this aim, 200 multiple myeloma patients will receive one of two different light-treatments that are designed to promote circadian rhythm alignment. While receiving these light treatments, participants' sleep efficiency, urine melatonin levels, blood inflammatory cytokine levels and symptoms will be assessed over a 2-month period.
CONDITIONS
Official Title
The Ambient Light Multiple Myeloma Study
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Diagnosed with Multiple Myeloma
- Scheduled for their first Autologous Stem Cell Transplant procedure
- 21 years of age or older
- Able to provide informed consent
- Proficient in English
You will not qualify if you...
- Prior Autologous Stem Cell Transplant procedure
- Pregnancy
- Eye diseases limiting light processing
- Secondary cancer diagnosis within the last 5 years
- Severe sleep disorders
- History of bipolar disorder or manic episodes
- Severe psychological impairment
- Previous use of light therapy
- Active infection including COVID-19
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 2 locations
1
Icahn Schoool of Medicine at Mount Sinai
New York, New York, United States, 10029
Actively Recruiting
2
Memorial Sloan Kettering Cancer Center
New York, New York, United States, 10065
Actively Recruiting
Research Team
B
Barbara Plitnick, BSN
CONTACT
M
Mariana Figueiro, PhD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
QUADRUPLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here